Scleroderma epidemiology☆
Section snippets
Incidence and prevalence
Table 1 lists U.S. studies that reported SSc incidence, prevalence, and sex distribution over a 44-year period (1947 through 1991). The Medsger and Masi study [5] was based on 86 hospitalized cases from 1947 to 1968; they derived, rather than measured, the prevalence estimate by multiplying the incidence rate (number of new cases per year) by survival in years. The Michet et al study [7] was based on 13 cases that were identified between 1950 and 1979 in Rochester, Minnesota. The Steen et al
Sex differences
As noted in Table 1, Table 2, female-to-male ratios differ somewhat among the studies but a female excess was a consistent finding. Steen et al [9] found that the excess of female cases compared with male cases is more marked in the child-bearing years compared with older age groups (3.8:1 vs. 2.4:1). This difference, however, is not as great as in SLE, where the incidence rate for women of child-bearing age is six- to ten-fold greater than that of similarly aged men [7], [25]. The implication
Racial and ethnic factors
Several United States studies have suggested that black patients have a higher age-specific incidence rate and more severe disease than white patients [9], [30]. Fig. 1, Fig. 2 show age-specific incidence rates of diffuse and limited SSc in 398 Michigan women by race for the period 1985 through 1991.
Figure 1 shows a peak age-specific incidence (20/million/year) of diffuse disease in black women in the 35- to 44-year age group. This is higher and earlier than the peak age-specific incidence of
Familial scleroderma
Some racial and ethnic groups have an increased incidence of SSc which implies that there may be a shared genetic predisposition. There have been numerous case reports of SSc occurring in more than one family member [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75] (for review see [76]). Two population studies investigated
Survival
Improved survival rates were reported in recent studies [30], [83], [84], [85], [86], [87], [88] compared with earlier ones [6], [89]. This improvement is apparent and real. Earlier diagnosis is a factor that artifactually prolongs observed survival. Additionally, survivor bias, in which the rapidly progressive and fatal diffuse cases are usually not captured at the same frequency as the more mild limited cases with protracted courses, prejudices studies in the direction of increased survival.
Geographic clusters
There have been several reports of clustering of SSc in particular areas. A cluster can be defined as a greater than expected occurrence of disease cases, in a geographically defined region, that is unlikely to have resulted by chance alone [92]. Two elements are necessary in determining a cluster: (1) the underlying disease prevalence and incidence rates should be known with some reliability; and (2) the boundaries of the geographic area must reasonably conform to natural population patterns,
Summary
Evidence from multiple sources indicates that SSc does not occur randomly in the population; there are particular groups who are at greater risk. The overall incidence rate of SSc in the adult population of the United States is approximately 20 per million per year; this rate has increased from 1944 to 1973, but has been relatively stable since that time. The prevalence of SSc in the United States also seems to be stable over the past two decades with a prevalence estimate for adults of 240 per
References (94)
- et al.
Epidemiology of systemic lupus erythematosus and other connective tissue disease in Rochester, Minnesota, 1950 through 1979
Mayo Clin Proc
(1985) - et al.
Genetics of systemic lupus erythematosus
Rheum Dis Clin North Am
(1992) - et al.
Systemic sclerosis in three US ethnic groups: a comparison of clinical sociodemographic, serologic, and immunogenetic determinants
Semin Arthritis Rheum
(2001) - et al.
Familial clustering of scleroderma spectrum disease
Am J Med
(1988) - et al.
South Australian scleroderma register: analysis of deceased patients
Pathology
(1998) Classification of progressive systemic sclerosis (scleroderma)
- et al.
Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis
J Rheumatol
(1988) Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Arthritis Rheum
(1980)- et al.
Predictors of survival in systemic sclerosis (scleroderma)
Arthritis Rheum
(1991) - et al.
Epidemiology of systemic sclerosis (scleroderma)
Ann Intern Med
(1971)
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients
Ann Intern Med
Comment on scleroderma criteria cooperative study
Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982
Arthritis Rheum
Prevalence of scleroderma spectrum disorders in the general population of South Carolina
Arthritis Rheum
Prevalence, incidence and survival rates of systemic sclerosis in the Detroit Metropolitan Area
Arthritis Rheum
Long-term survival of scleroderma renal crisis and malignant hypertension with captopril
Epidemiology of rheumatoid arthritis: update
Epidemiol Rev
Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period
Arthritis Rheum
Rheumatoid arthritis in women: incidence rates in Group Health Cooperative, Seattle, Washington, 1987–1989
Arthritis Rheum
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of its incidence, prevalence, and mortality
Am J Epidemiol
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century
Rheumatology
Incidence of rheumatoid arthritis in Finland during 1980–1990
Ann Rheum Dis
Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992
Arthritis Rheum
An epidemiologic study of scleroderma in the West Midlands
Br J Rheumatol
Epidemiologic study of patients with systemic sclerosis in Tokyo
Arch Dermatol Res
Systemic sclerosis in Iceland. A nationwide epidemiologic study
Ann Rheum Dis
Scleroderma in South Australia: epidemiological observations of possible pathogenic significance
Int Med J
Systemic sclerosis prevalence and mortality in Sydney 1974–1988
Aust N Z J Med
Sex effects in systemic lupus erythematosus: a clue to pathogenesis
Arthritis Rheum
Reproductive history, oral contraceptive use, estrogen replacement therapy and the risk of developing scleroderma
Arthritis Rheum
Reproductive factors and the risk of scleroderma: an Italian case-control study
Arthritis Rheum
Influence of prior pregnancies on disease course and cause of death in systemic sclerosis
Ann Rheum Dis
Relationship between parity and clinical and biological features in patients with systemic sclerosis
J Rheumatol
Racial differences in scleroderma among women in Michigan
Arthritis Rheum
Connective tissue disease in southeast Georgia. A community-based study of immunogenetic markers and autoantibodies
J Rheumatol
HLA and autoimmunity in scleroderma (systemic sclerosis)
Int Rev Immunol
Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma
Arthritis Rheum
Racial differences in the frequencies of scleroderma-related autoantibodies
Arthritis Rheum
Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype
Arthritis Rheum
Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis
J Rheumatol
Familial Raynaud's phenomenon and localized scleroderma associated with essential telangiectasia and cytogenetic abnormalities
J R Soc Med
Familial” scleroderma
Arch Dermatol
Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors
Ann Ital Med Int
Familial scleroderma with Sjogren's syndrome and lymphocyte and chromosome abnormalities
Ann Med Interne (Paris)
Features of systemic sclerosis (scleroderma) in an identical twin pair
Br J Rheumatol
An immunogenetic study of familial scleroderma
Ann Rheum Dis
Occurrence of scleroderma in monozygotic twins
J Rheumatol
Cited by (223)
Multimodality imaging of the gastrointestinal manifestations of scleroderma
2021, Clinical RadiologyPeripheral nervous system manifestations of rheumatological diseases
2021, Journal of the Neurological SciencesEconomic and Health Care Resource Use Burden of Systemic Sclerosis
2023, ACR Open RheumatologyNoninvasive electrical neuromodulation for gastrointestinal motility disorders
2023, Expert Review of Gastroenterology and Hepatology
- ☆
This article was supported by grants no. NIAMS/NIH N01-AR-5-2217 and N01-AR-0-2251.